tiprankstipranks
Trending News
More News >
Moderna (MRNA)
NASDAQ:MRNA
US Market

Moderna (MRNA) Technical Analysis

Compare
17,274 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
3Neutral
8Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Moderna’s (MRNA) Moving Averages Convergence Divergence (MACD) indicator is 0.67, suggesting Moderna is a Sell.
Moderna’s (MRNA) 20-Day exponential moving average is 27.56, while Moderna’s (MRNA) share price is $30.49, making it a Buy.
Moderna’s (MRNA) 50-Day exponential moving average is 27.55, while Moderna’s (MRNA) share price is $30.49, making it a Buy.

Moderna (MRNA) Pivot Points

Jul 07, 2025, 11:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
27.02
27.82
29.05
29.85
31.08
31.88
33.11
Fibonacci
27.82
28.60
29.07
29.85
30.63
31.10
31.88
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Moderna (MRNA) Moving Averages

Jul 07, 2025, 11:22 AM
Period
Simple
Exponential
MA5
28.84Buy
29.18Buy
MA10
27.70Buy
28.27Buy
MA20
27.25Buy
27.56Buy
MA50
26.70Buy
27.55Buy
MA100
28.82Buy
31.11Sell
MA200
38.22Sell
44.10Sell
Moderna’s (MRNA) 10-Day exponential moving average is 28.27, while Moderna’s (MRNA) share price is $30.49, making it a Buy.
Moderna’s (MRNA) 100-Day exponential moving average is 31.11, while Moderna’s (MRNA) share price is $30.49, making it a Sell.
Moderna’s (MRNA) stock price is $30.49 and Moderna’s (MRNA) 50-day simple moving average is 26.70, creating a Buy signal.
Moderna’s (MRNA) stock price is $30.49 and Moderna’s (MRNA) 100-day simple moving average is 28.82, creating a Buy signal.
Moderna’s (MRNA) stock price is $30.49 and Moderna’s (MRNA) 200-day simple moving average is 38.22, creating a Sell signal.

Moderna (MRNA) Technical Indicators

Jul 07, 2025, 11:22 AM
Name
Value
Implied Action
RSI (14)
67.79
Neutral
STOCH (9,6)
87.11
Sell
STOCHRSI (14)
87.20
Sell
MACD (12,26)
0.67
Sell
ADX (14)
23.03
Neutral
Williams %R
-7.65
Sell
CCI (14)
209.05
Sell
ATR (14)
1.41
-
Ultimate Oscillator
54.66
Neutral
ROC
11.48
Buy
Moderna’s (MRNA) Relative Strength Index (RSI) is 67.79, creating a Neutral signal.
Moderna’s (MRNA) Trend Strength Indicator (ADX) is 23.03, creating a Neutral signal.
Moderna’s (MRNA) Commodity Channel Index (CCI) is 209.05, creating a Sell signal.
Moderna’s (MRNA) Price Rate of Change (ROC) is 11.48, creating a Buy signal.

FAQ

Is MRNA a Buy, Hold, or Sell?
Based on MRNA’s technical indicators, MRNA is a Buy.
    What is MRNA’s RSI (14)?
    MRNA’s RSI (14) is 67.79, which suggests MRNA is a Neutral.
      What is MRNA’s MACD?
      MRNA’s MACD is 0.67, which suggests MRNA is a Sell.
        What is MRNA’s 5-day moving average?
        MRNA’s 5-day moving average is 28.84, which suggests MRNA is a Buy.
          What is MRNA’s 20-day moving average?
          MRNA 20-day moving average is 27.25, which suggests MRNA is a Buy.
            What is MRNA’s 50-day moving average?
            MRNA’s 50-day moving average is 26.70, which suggests MRNA is a Buy.
              What is MRNA’s 200-day moving average?
              MRNA’s 200-day moving average is 38.22, which suggests MRNA is a Sell.
                What is MRNA’s Williams % R (14)?
                MRNA’s Williams % R (14) is -7.65, which suggests MRNA is a Sell.
                  What is MRNA’s CCI (14)?
                  MRNA’s CCI (14) is 209.05, which suggests MRNA is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis